Florian Rieder
Cleveland Clinic Foundation
Appearances
DateMay 8, 2023SOCIETY: AGAModerators
Cleveland Clinic FoundationCase Western Reserve University School of Medicine
DateMay 9, 2023BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…Presenter
Icahn School of Medicine at Mount Sinai- DateMay 9, 2023Background: Mesenteric fat wrapping around the intestinal wall, so called ‘creeping fat’ (CF), is spatially linked with stricture formation in Crohn’s disease (CD)…
- DateMay 20, 2024
Presenter
Cleveland Clinic Foundation - DateMay 20, 2024
Presenters
Cleveland Clinic FoundationBoston Children's HospitalDepartment of Pathology & Laboratory Medicine Rutgers New Jersey School of MedicineIcahn School of Medicine at Mount Sinai - DateMay 20, 2024BACKGROUND: Inflammatory bowel disease (IBD)-associated intestinal fibrosis is a significant clinical problem. Excessive accumulation of extracellular matrix (ECM) derived from intestinal myofibroblasts (HIMF) is a hallmark of intestinal strictures…
Presenter
- DateMay 18, 2024Intestinal fibrosis is a significant clinical challenge in inflammatory bowel diseases, but no effective anti-fibrotic therapy is currently available. GCGR and GLP1R are both peptide hormone receptors involved in energy metabolism of epithelial cells…
Presenter
- DateMay 21, 2024Eosinophilic esophagitis (EoE) is a chronic immune mediated esophageal condition leading to dysphagia, strictures, and food impactions. Endoscopic biopsies remain the gold standard for diagnosis…
Presenter
Speakers
Virginia Commonwealth UniversityCleveland Clinic Foundation - DateMay 20, 2024
Presenter
Cleveland Clinic Foundation - DateMay 21, 2024_INTRODUCTION:_ Despite effective anti-inflammatory therapies, ~70% of CD patients require surgery in their lifetime, due to fibrostenotic strictures linked to excess extracellular matrix (ECM) deposition…
Presenter
- DateMay 21, 2024The evaluation of volatile organic compounds (VOCs) in exhaled breath shows promise as an entirely non-invasive strategy to evaluate for inflammation with high patient acceptance…
Presenter
Speakers
Cleveland ClinicCleveland Clinic Foundation 
DateMay 19, 2024SOCIETY: AGAModerators
University of California DavisCleveland Clinic Foundation- DateMay 5, 2025This session highlights the best of the best in basic and clinical science inflammatory bowel diseases research submitted to DDW 2025 and will cover novel genetic variants and gene expression patterns linked with disease, recent findings on the role of the gut microbiota on disease pathogenesis and…
Moderators
Massachusetts General HospitalCleveland Clinic Foundation
